Latest Period
Q1 2026
Security Snapshot
Xilio Therapeutics, Inc. - COM (XLO) Institutional Ownership
CUSIP: 98422T209
13F Institutional Holders and Ownership History for Q1 2026
Institutions Reporting
23
Shares (Excl. Options)
1,969,092
Price
$8.41
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Type / Class
- Equity / COM
- Symbol
- XLO on Nasdaq
- Price per share
- $8.18
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 1,969,092
- Total reported value
- $16,560,762
- % of total 13F portfolios
- 0%
- Share change
- +1,816,747
- Value change
- +$15,279,540
- Number of holders
- 23
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- XLO - Xilio Therapeutics, Inc. - COM is tracked under CUSIP 98422T209.
- 23 institutions reported positions in Q1 2026.
- Schedule 13D/13G significant owner rows are not currently available.
What Changed
- Latest quarter on this page is Q1 2026.
- Additional quarter-over-quarter change detail appears as history expands.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Source Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 23 institutions filings for Q1 2026.
Investment Quick Answers
What is CUSIP 98422T209?
CUSIP 98422T209 identifies XLO - Xilio Therapeutics, Inc. - COM in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q1 2026 holders report and the ownership history table below.
Next ownership checks
Use the next link that matches the question you still need to answer about this security.
- Latest 13F filings when you want to inspect fresh institutional portfolio moves.
- Latest Schedule 13D/13G reports when you need large-owner changes outside the 13F cycle.
- All institutional ownership pages to compare this security with other holder-history pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 98422T209:
As of 31 Mar 2026, 23 institutional investors reported holding 1,969,092 shares of Xilio Therapeutics, Inc. - COM (XLO).
Institutional Holders of Xilio Therapeutics, Inc. - COM (XLO) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 1,969,092 | $16,560,762 | +$15,279,540 | $8.41 | 23 |